- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 6, 2026 | 516.88M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 517M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 531M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $67M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $537M |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $232M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $220M |
| Capex | Q1 2026 · Mar 31, 2026 | $50M |
| Capex | Q1 2026 · Mar 31, 2025 | $37M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $16.79B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $9.07B |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $4.16B |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $2.73B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $755M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $599M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $15.98B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $13.9B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $8.47B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $7.62B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $27.5B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $19.59B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $4.98B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $4.49B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $43.48B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $33.49B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $4.58 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.15 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $4.59 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.15 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $605M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $558M |
| Net Income | Q1 2026 · Mar 31, 2026 | $2.37B |
| Net Income | Q1 2026 · Mar 31, 2025 | $77M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $423M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $347M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $1.11B |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $879M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $2.19B |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $1.65B |
| Revenue | Q1 2026 · Mar 31, 2026 | $3.3B |
| Revenue | Q1 2026 · Mar 31, 2025 | $2.53B |